Dual modifications of α-galactosylceramide synergize to promote activation of human invariant natural killer t cells and stimulate anti-tumor immunity (Cell chemical biology, 2018)

(untitled) - Chennamadhavuni, D; Saavedra-Avila, NA; Carreño, LJ; Guberman-Pfeffer, MJ; Arora, P; Yongqing, T; Pryce, R; Koay, H-F; Godfrey, DI; Keshipeddy, S; Richardson, SK; Sundararaj, S; et al.